Abbott Laboratories (ABT) NYSE
86.25
-0.925(-1.06%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
86.25
-0.925(-1.06%)
Currency In USD
| Market Cap | 218.88B |
| Enterprise Value | 225.43B |
| P/E Ratio | 24.01 |
| PEG Ratio | -0.45 |
| Price/Sales Ratio | 3.33 |
| Price/Book Ratio | 2.89 |
| Enterprise/Revenue | 3.93 |
| Enterprise/EBITDA | 16.43 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.14 |
| Operating Margin | 0.18 |
| Return On Assets | 0.06 |
| Return On Equity | 0.12 |
| Revenue | 44.33B |
| Revenue/Share | 25.84 |
| Gross Profit | 24.61B |
| EBITDA | 11.55B |
| Net Income | 6.52B |
| Diluted EPS | 3.72 |
| Total Cash | 7.3B |
| Total Cash/Share | 4.18 |
| Total Debt | 34.05B |
| Total Debt/Equity | 0.65 |
| Current Ratio | 1.39 |
| Book Value Per Share | 30.17 |
| 52-Week Change | -35.61 |
| 52-Week High | 139.06 |
| 52-Week Low | 86.15 |
| Moving Average 50 Days | 103 |
| Moving Average 200 Days | 120.2 |
| Average Volume | 13.04M |
| Shares Outstanding | 1.74B |
| % Held by Institutions | 81.76 |
| Trailing Annual Dividend Rate | 2.44 |
| Trailing Annual Dividend Yield | 2.83 |
| Payout Ratio | 0.67 |
| Last Split Factor | 5000:2399 |
| Last Split Date | January 02, 2013 |